|
Market Closed -
NYSE
04:00:00 2026-10-27 pm EDT
|
5-day change | 1st Jan Change | ||
| 2.530 USD | +2.02% |
|
-1.17% | +40.56% |
| Market Cap | 200M 180M 166M 150M 281M 19B 284M 1.99B 790M 9.96B 750M 734M 31.57B | P/E 2026 * |
10.3x | P/E 2027 * | 49.6x |
|---|---|---|---|---|---|
| Enterprise Value | 200M 180M 166M 150M 281M 19B 284M 1.99B 790M 9.96B 750M 734M 31.57B | EV / Sales 2026 * |
2.43x | EV / Sales 2027 * | 3.01x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
|
Tradegate
| PBDA | Real-time | |
|
Börse Stuttgart
| PBDA | Delayed | |
|
Deutsche Boerse AG
| PBDA | Delayed | |
|
Boerse Muenchen
| PBDA | Real-time |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | +2.02% | ||
| 1 week | -1.17% | ||
| Current month | -8.33% | ||
| 1 month | -6.99% | ||
| 3 months | +6.75% | ||
| 6 months | +16.06% | ||
| Current year | +40.56% |
| 1 week | 2.46 |  | 2.64 |
| 1 month | 2.46 | | 2.82 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.65 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 2019-06-29 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 2025-08-23 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 2008-06-30 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 2014-10-31 |
Dror Bashan
BRD | Director/Board Member | 59 | 2019-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/3/26 | Free | Director | 25,500 | 0.0316% | ||
| 9/3/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 9/3/26 | Free | Chief Executive Officer | 480,000 | 0.5957% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.02% | -1.17% | +7.20% | +69.80% | 200M | |
| +0.22% | +3.35% | +55.30% | +125.65% | 1,140B | |
| +0.91% | +5.89% | +41.14% | +80.36% | 641B | |
| -0.12% | +1.31% | +25.62% | +97.24% | 507B | |
| +0.63% | +4.97% | +47.12% | +68.18% | 383B | |
| +0.86% | -1.26% | +62.10% | +34.36% | 347B | |
| +1.02% | +3.69% | +23.73% | +51.35% | 293B | |
| -0.25% | +3.40% | +2.31% | +23.38% | 266B | |
| +0.75% | +5.41% | +53.53% | +66.09% | 240B | |
| +0.25% | +3.93% | +31.54% | +102.65% | 197B | |
| Average | +0.34% | +2.32% | +34.96% | +71.90% | 401.4B | |
| Weighted average by Cap. | +0.02% | +2.98% | +42.01% | +84.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 82.16M 73.82M 68.1M 61.75M 115M 7.81B 117M 817M 325M 4.09B 308M 302M 12.98B | 66.48M 59.73M 55.1M 49.97M 93.41M 6.32B 94.61M 661M 263M 3.31B 250M 244M 10.5B |
| Net income | 19.63M 17.64M 16.27M 14.76M 27.58M 1.87B 27.94M 195M 77.57M 978M 73.69M 72.11M 3.1B | 3.79M 3.41M 3.14M 2.85M 5.33M 361M 5.4M 37.74M 14.99M 189M 14.24M 13.93M 599M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | $2.530 | +2.02% | 448,300 |
| 26-10-26 | $2.480 | -2.75% | 416,271 |
| 26-10-23 | $2.550 | -0.78% | 383,908 |
| 26-10-22 | $2.570 | 0.00% | 457,114 |
| 26-10-21 | $2.570 | -2.65% | 561,517 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
